PARADIGM BIOCAPITAL ADVISORS LP – Syndax Pharmaceuticals, Inc. Transaction History
PARADIGM BIOCAPITAL ADVISORS LP portfolio value:
$26.07M
portfolio value
PARADIGM BIOCAPITAL ADVISORS LP quarter portfolio value change:
+24.90%
quarter
Syndax Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +23.85% | 208.98K shares | 9.21M | $24.03 | 1.08M |
| Q2 2022 | share | Increase | +24.92% | 174.8K shares | 4.66M | $19.24 | 876.15K |
| Q1 2022 | share | Increase | +54.79% | 248.26K shares | 2.27M | $17.38 | 701.35K |
| Q4 2021 | share | Increase | 0.00% | 453.09K shares | 9.91M | $21.78 | 453.09K |